Previous close | 43.90 |
Open | 43.98 |
Bid | 43.94 x 3000 |
Ask | 43.95 x 3200 |
Day's range | 43.83 - 44.26 |
52-week range | 43.33 - 69.10 |
Volume | |
Avg. volume | 15,555,657 |
Market cap | 89.273B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.40 (5.47%) |
Ex-dividend date | 04 Apr 2024 |
1y target est | N/A |
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....